Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/J.AMJMED.2004.03.044PMID 15639212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016cited by this paper
• Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

  2012cited by this paper
• Cochrane Reviews and Systematic Reviews of Economic Evaluations

  2012cited by this paper
• Do hospital employees benefit from the influenza vaccine?

  2007cited by this paper
• Management of influenza symptoms in healthy adults

  2003cited by this paper
• Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults

  2002cited by this paper
• Cost-effectiveness of newer treatment strategies for influenza.

  2002cited by this paper
• Influenza Vaccination, Hospitalizations, and Costs Among Members of a Medicare Managed Care Plan

  2001cited by this paper
• Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.

  2001cited by this paper
• Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults.

  2001cited by this paper
• What you charge vs what you get.

  2001cited by this paper
• Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

  2001cited by this paper
• Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

  2001cited by this paper
• Surveillance for influenza--United States, 1994-95, 1995-96, and 1996-97 seasons.

  2000cited by this paper
• The impact of influenza epidemics on hospitalizations.

  2000cited by this paper
• Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.

  2000cited by this paper
• Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

  2000cited by this paper
• Cost of treating influenza in emergency department and hospital settings.

  2000cited by this paper
• Predicting influenza infections during epidemics with use of a clinical case definition.

  2000cited by this paper
• Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

  2000cited by this paper
• Vaccines for preventing influenza in healthy adults.

  2000cited by this paper
• Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

  2000cited by this paper
• Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.

  2000cited by this paper
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

  2000cited by this paper
• Effectiveness of influenza vaccine in health care professionals: a randomized trial.

  1999cited by this paper
• Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers.

  1999cited by this paper
• The socio-economic burden of influenza.

  1999cited by this paper
• The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.

  1999cited by this paper
• The economic impact of pandemic influenza in the United States: priorities for intervention.

  1999cited by this paper
• Influenza-associated morbidity and mortality in young and middle-aged women.

  1999cited by this paper
• Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

  1999cited by this paper
• Current estimates from the National Health Interview Survey, 1996.

  1999cited by this paper
• Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

  1999cited by this paper
• Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

  1999cited by this paper
• Absenteeism among employees who participated in a workplace influenza immunization program.

  1998cited by this paper
• The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

  1998cited by this paper
• Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

  1998cited by this paper
• The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population.

  1998cited by this paper
• Influenza surveillance--United States, 1992-93 and 1993-94.

  1997cited by this paper
• Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

  1997cited by this paper
• Influenza vaccination among healthy employees: a cost-benefit analysis.

  1997cited by this paper
• Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients

  1997cited by this paper
• The congressional Office of Technology Assessment

  1997cited by this paper
• Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial.

  1996cited by this paper
• Current estimates from the National Health Interview Survey, 1994.

  1995cited by this paper
• The effectiveness of vaccination against influenza in healthy, working adults.

  1995cited by this paper
• Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

  1995cited by this paper
• The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

  1994cited by this paper
• A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.

  1982cited by this paper
• Cost-effectiveness of flu vaccine. Congressional Office of Technology Assessment.

  1982cited by this paper
• Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

  1981cited by this paper
• Impact of epidemic type A influenza in a defined adult population.

  1980cited by this paper
• Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

  1969cited by this paper

• Cost-effectiveness of annual trivalent inactivated influenza vaccine program by age and risk status

  2026cites this paper
• Utilizing Strategies of Masks and Retroactive Treatment for Epidemic Disease Control on Behavioral Dynamics

  2025cites this paper
• Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis

  2024cites this paper
• Cost-effectiveness of routine annual influenza vaccination by age and risk status.

  2023cites this paper
• A cyclic behavioral modeling aspect to understand the effects of vaccination and treatment on epidemic transmission dynamics

  2023cites this paper
• Determining the impact of vitamin C use with the common cold on loss of labour and medical treatment costs for Turkey

  2021cites this paper
• The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

  2021cites this paper
• Costs per DALYs Averted of Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccine in Elderly Population in Thailand

  2021cites this paper
• Economic evaluations of interventions against influenza at workplaces: systematic review.

  2021cites this paper
• Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

  2020cites this paper
• How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself

  2020cites this paper
• Comparison of influenza hospitalization outcomes among adults, older adults, and octogenarians: A US national population-based study.

  2020cites this paper
• Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea.

  2020cites this paper
• Model-based economic evaluations of diagnostic point of care tests were rarely fit for purpose.

  2019influential citation
• Shades of gray in vaccine decision making: Understanding, exploring, and addressing the challenges of influenza vaccine hesitancy in Ontario community pharmacies

  2019cites this paper
• Cost-effectiveness of adult vaccinations: A systematic review.

  2019cites this paper
• Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic

  2018cites this paper
• Impact of Pharmacist Immunization Authority on Seasonal Influenza Immunization Rates Across States.

  2017cites this paper
• Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.

  2016cites this paper
• Influenza Vaccination Coverage Rate according to the Pulmonary Function of Korean Adults Aged 40 Years and Over: Analysis of the Fifth Korean National Health and Nutrition Examination Survey

  2016cites this paper
• Weekends as social distancing and their effect on the spread of influenza

  2016cites this paper
• An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.

  2015cites this paper
• Compliance with Vaccination Against Influenza Among the Elderly.

  2015cites this paper
• Pulmonary Infection

  2015cites this paper
• A Community Partnership to Respond to an Outbreak: A Model that Can Be Replicated for Future Events

  2015cites this paper
• Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis

  2015cites this paper
• Quantifying the Economic Value and Quality of Life Impact of Earlier Influenza Vaccination

  2015cites this paper
• Structure et dynamique du peptide de fusion membranaire du virus Influenza et son impact sur la membrane

  2014cites this paper
• Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines

  2014cites this paper
• Influenza vaccination coverage among school employees: assessing knowledge, attitudes, and behaviors.

  2014cites this paper
• Universal paid leave increases influenza vaccinations among employees in the U.S.

  2014cites this paper
• Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age

  2013cites this paper
• Selecting Nonpharmaceutical Interventions for Influenza

  2013cites this paper
• Economic analyses of vaccine policies

  2013cites this paper
• Seasonal Influenza Vaccination of Healthy Working-Age Adults

  2012influential citation
• The decision to receive influenza vaccination among nurses in North and South Dakota.

  2012cites this paper
• Supporting Public Health Policy Decision-making through Economic Evaluation: Applications and Methods

  2012cites this paper
• Issues in the Economic Evaluation of Influenza Vaccination by Injection of Healthy Working Adults in the US

  2012cites this paper
• The influence of altruism on influenza vaccination decisions

  2012cites this paper
• The Comparative Value of Various Employer-Sponsored Influenza Vaccination Clinics

  2012cites this paper
• Planning influenza vaccination programs: a cost benefit model

  2012influential citation
• Implementing an Influenza Vaccination Programme for Adults Aged ≥ 65 Years in Poland

  2012influential citation
• Impact of Program Scale and Indirect Effects on the Cost-Effectiveness of Vaccination Programs

  2012cites this paper
• Cost Effectiveness of Influenza Vaccination in Older Adults

  2012cites this paper
• Decision support for containing pandemic propagation

  2011cites this paper
• Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine

  2011cites this paper
• The Role of Subway Travel in an Influenza Epidemic: A New York City Simulation

  2011cites this paper
• The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA

  2011cites this paper
• From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.

  2011cites this paper
• Influenza-Like Illness Among University Students: Symptom Severity and Duration Due to Influenza Virus Infection Compared to Other Etiologies

  2011cites this paper
• The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities.

  2011cites this paper
• Economic Implications of Influenza and Influenza Vaccine

  2010cites this paper
• Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults.

  2010cites this paper
• Health Behaviors of Employed and Insured Adults in the United States, 2004-2005

  2010cites this paper
• Resource allocation for demand surge mitigation during disaster response

  2010cites this paper
• Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts

  2010cites this paper
• Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination.

  2010cites this paper
• Protecting health care workers: a pandemic simulation based on Allegheny County

  2010cites this paper
• Simulating school closure strategies to mitigate an influenza epidemic.

  2010cites this paper
• Decision Making with Regard to Antiviral Intervention during an Influenza Pandemic

  2010cites this paper
• Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

  2010cites this paper
• Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis

  2010cites this paper
• Influenza vaccination rates among pharmacists.

  2010cites this paper
• Economics of influenza vaccine administration timing for children.

  2010cites this paper
• A computer simulation of employee vaccination to mitigate an influenza epidemic.

  2010cites this paper
• To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer Modeling

  2010cites this paper
• Improving influenza vaccination rates in the workplace: a randomized trial.

  2010cites this paper
• Economic value of seasonal and pandemic influenza vaccination during pregnancy.

  2009cites this paper
• Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

  2009cites this paper
• Impact of Vaccinating HCWs on the Ward and Possible Influence of Avian Flu Threat

  2009cites this paper
• Racial and Ethnic Disparities in Pneumonia Treatment and Mortality

  2009cites this paper
• Coverage of Influenza Vaccination among Elderly in South Korea: A Population Based Cross Sectional Analysis of the Season 2004-2005

  2009cites this paper
• PROPOSAL FOR THE INCLUSION OF AMANTADINE AND RIMANTADINE IN THE WORLD HEALTH ORGANISATION MODEL LIST OF ESSENTIAL MEDICINES

  2009cites this paper
• The timing of influenza vaccination for older adults (65 years and older).

  2009cites this paper
• Antiviral Medications for Pregnant Women for Pandemic and Seasonal Influenza: An Economic Computer Model

  2009cites this paper
• Recommendations for the prevention and treatment of influenza using antiviral drugs based on cost–effectiveness

  2008cites this paper
• Influenza Vaccination

  2008cites this paper
• Comparaison coût/bénéfice de la campagne vaccinale et de la réduction de l’absentéisme, après vaccination contre la grippe du personnel du CHU de Clermont-Ferrand

  2008cites this paper
• Improving Immunization Rates: Initial Results From a Team-Based, Systems Change Approach

  2008cites this paper
• The Impact of Influenza on Working Days Lost

  2008cites this paper
• Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons

  2008cites this paper
• Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes

  2008cites this paper
• [Cost/effectiveness comparison of the vaccine campaign and reduction of sick leave, after vaccination against influenza among the Clermont-Ferrand University Hospital staff].

  2008cites this paper
• Cost-effectiveness of gargling for the prevention of upper respiratory tract infections

  2008cites this paper
• Eficiencia de los fármacos de origen biotecnológico en el marco terapéutico actual, según los estudios farmacoeconómicos disponibles

  2008cites this paper
• Tobacco smoking and thyroid function: is weight gain a confounder?

  2008cites this paper
• Preattack vaccination against anthrax may be cost-effective in certain populations.

  2008cites this paper
• Clinical data on Fluarix®: an inactivated split seasonal influenza vaccine

  2008cites this paper
• Economic evaluation of prevention; further evidence

  2007cites this paper
• Influenza vaccination for healthy adults

  2007cites this paper
• Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development

  2007cites this paper
• Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.

  2007cites this paper
• The time horizons of formal decision analyses.

  2007cites this paper
• Economic consequences of established rheumatoid arthritis and its treatment.

  2007cites this paper
• Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic.

  2007cites this paper
• Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression.

  2006cites this paper
• The pharmacoeconomics of newer therapeutics for rheumatic diseases.

  2006cites this paper
• CME-CERTIFIED MONOGRAPH AND ACCOMPANYING SLIDE SET

  2006cites this paper
• Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos

  2006cites this paper
• [Analysis of a economic model of a populational influenza immunization strategy in healthy employees].

  2006cites this paper